APA ציטוט

Ruilope, L. M., Redón, J., & Schmieder, R. (2007). Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme. Dove Medical Press.

Citação norma Chicago

Ruilope, Luis Miguel, Josep Redón, and Roland Schmieder. Cardiovascular Risk Reduction By Reversing Endothelial Dysfunction: ARBs, ACE Inhibitors, or Both? Expectations From The ONTARGET Trial Programme. Dove Medical Press, 2007.

ציטוט MLA

Ruilope, Luis Miguel, Josep Redón, and Roland Schmieder. Cardiovascular Risk Reduction By Reversing Endothelial Dysfunction: ARBs, ACE Inhibitors, or Both? Expectations From The ONTARGET Trial Programme. Dove Medical Press, 2007.